These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 37061743)

  • 1. Epigenetically regulated gene expression profiles decipher four molecular subtypes with prognostic and therapeutic implications in gastric cancer.
    Weng S; Li M; Deng J; Xu H; Ren Y; Zhou Z; Wang L; Zhang Y; Xing Z; Li L; Liu Z; Han X
    Clin Epigenetics; 2023 Apr; 15(1):64. PubMed ID: 37061743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetically regulated gene expression profiles reveal four molecular subtypes with prognostic and therapeutic implications in colorectal cancer.
    Wang X; Liu J; Wang D; Feng M; Wu X
    Brief Bioinform; 2021 Jul; 22(4):. PubMed ID: 33300554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
    Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
    Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular classification reveals the diverse genetic and prognostic features of gastric cancer: A multi-omics consensus ensemble clustering.
    Hu X; Wang Z; Wang Q; Chen K; Han Q; Bai S; Du J; Chen W
    Biomed Pharmacother; 2021 Dec; 144():112222. PubMed ID: 34607103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integration of transcriptomics, proteomics, and metabolomics data to reveal HER2-associated metabolic heterogeneity in gastric cancer with response to immunotherapy and neoadjuvant chemotherapy.
    Yuan Q; Deng D; Pan C; Ren J; Wei T; Wu Z; Zhang B; Li S; Yin P; Shang D
    Front Immunol; 2022; 13():951137. PubMed ID: 35990657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated epigenomics identifies BMP4 as a modulator of cisplatin sensitivity in gastric cancer.
    Ivanova T; Zouridis H; Wu Y; Cheng LL; Tan IB; Gopalakrishnan V; Ooi CH; Lee J; Qin L; Wu J; Lee M; Rha SY; Huang D; Liem N; Yeoh KG; Yong WP; Teh BT; Tan P
    Gut; 2013 Jan; 62(1):22-33. PubMed ID: 22535375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrinsic subtypes of gastric cancer, based on gene expression pattern, predict survival and respond differently to chemotherapy.
    Tan IB; Ivanova T; Lim KH; Ong CW; Deng N; Lee J; Tan SH; Wu J; Lee MH; Ooi CH; Rha SY; Wong WK; Boussioutas A; Yeoh KG; So J; Yong WP; Tsuburaya A; Grabsch H; Toh HC; Rozen S; Cheong JH; Noh SH; Wan WK; Ajani JA; Lee JS; Tellez MS; Tan P
    Gastroenterology; 2011 Aug; 141(2):476-85, 485.e1-11. PubMed ID: 21684283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of molecular subtypes of gastric cancer with different responses to PI3-kinase inhibitors and 5-fluorouracil.
    Lei Z; Tan IB; Das K; Deng N; Zouridis H; Pattison S; Chua C; Feng Z; Guan YK; Ooi CH; Ivanova T; Zhang S; Lee M; Wu J; Ngo A; Manesh S; Tan E; Teh BT; So JB; Goh LK; Boussioutas A; Lim TK; Flotow H; Tan P; Rozen SG
    Gastroenterology; 2013 Sep; 145(3):554-65. PubMed ID: 23684942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of intratumoural CD96 expression on clinical outcome and therapeutic benefit in gastric cancer.
    Xu C; Fang H; Gu Y; Yu K; Wang J; Lin C; Zhang H; Li H; He H; Liu H; Li R
    Cancer Sci; 2022 Dec; 113(12):4070-4081. PubMed ID: 35997524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of Immune-Related Molecular Subtypes and a Prognostic Signature Correlating With the Response to Immunotherapy in Patients With Gastric Cancer.
    Wang G; Yang L; Wang Y; Hu R; Zhang K; Guo T; Chen B; Jiang X; Cui R
    Front Immunol; 2022; 13():939836. PubMed ID: 35898512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cancer-associated fibroblast-related signature predicts prognosis and indicates immune microenvironment infiltration in gastric cancer.
    Mak TK; Li X; Huang H; Wu K; Huang Z; He Y; Zhang C
    Front Immunol; 2022; 13():951214. PubMed ID: 35967313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of miR-34c after silencing E2F transcription factor 1 inhibits paclitaxel combined with cisplatin resistance in gastric cancer cells.
    Zheng H; Wang JJ; Yang XR; Yu YL
    World J Gastroenterol; 2020 Feb; 26(5):499-513. PubMed ID: 32089626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated analysis from multicentre studies identities m7G-related lncRNA-derived molecular subtypes and risk stratification systems for gastric cancer.
    Ma M; Li J; Zeng Z; Zheng Z; Kang W
    Front Immunol; 2023; 14():1096488. PubMed ID: 36936957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer.
    Wang Y; Zhu GQ; Tian D; Zhou CW; Li N; Feng Y; Zeng MS
    BMC Cancer; 2022 Mar; 22(1):316. PubMed ID: 35331183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a Tumor Microenvironment-relevant Gene set-based Prognostic Signature and Related Therapy Targets in Gastric Cancer.
    Cai WY; Dong ZN; Fu XT; Lin LY; Wang L; Ye GD; Luo QC; Chen YC
    Theranostics; 2020; 10(19):8633-8647. PubMed ID: 32754268
    [No Abstract]   [Full Text] [Related]  

  • 16. Identification of a molecular signature of prognostic subtypes in diffuse-type gastric cancer.
    Kim SK; Kim HJ; Park JL; Heo H; Kim SY; Lee SI; Song KS; Kim WH; Kim YS
    Gastric Cancer; 2020 May; 23(3):473-482. PubMed ID: 31773340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Immune Subtypes and Landscape of Gastric Cancer and to Predict Based on the Whole-Slide Images Using Deep Learning.
    Chen Y; Sun Z; Chen W; Liu C; Chai R; Ding J; Liu W; Feng X; Zhou J; Shen X; Huang S; Xu Z
    Front Immunol; 2021; 12():685992. PubMed ID: 34262565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the subtypes of gastric cancer based on DNA methylation and the prediction of prognosis.
    Li T; Chen X; Gu M; Deng A; Qian C
    Clin Epigenetics; 2020 Oct; 12(1):161. PubMed ID: 33115518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA methylation signatures associated with prognosis of gastric cancer.
    Dai J; Nishi A; Li ZX; Zhang Y; Zhou T; You WC; Li WQ; Pan KF
    BMC Cancer; 2021 May; 21(1):610. PubMed ID: 34034702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor cell-expressed IL-15Rα drives antagonistic effects on the progression and immune control of gastric cancer and is epigenetically regulated in EBV-positive gastric cancer.
    Wei J; Guo C; An X; Miao W; Zhang C; Wang B; Cai W; Li M; Zhang F
    Cell Oncol (Dordr); 2020 Dec; 43(6):1085-1097. PubMed ID: 32767257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.